Sat, Jul 12, 2014, 7:02 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

bnordheimer 2 posts  |  Last Activity: Jun 26, 2014 8:48 AM Member since: Dec 1, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Old time investors

    by whatchutalkingbout Jun 25, 2014 5:46 PM
    bnordheimer bnordheimer Jun 26, 2014 8:48 AM Flag

    Still here and still long. Never sold one share. This is taking longer than anyone would want to see, but Garr, Johe and the team are systematically proving out their science and it shouldn't be too many more years before great numbers of patients can get real help. I think the point with NSI-566 is early recognition of the condition and then very early treatment with NSI-566 to halt progression while capability is still very much intact.

    NSI-189 represents a whole new world. IF it is what it seems to be, this tiny little company may literally change the world for millions of people.

    Combining the two approaches (stem cells and the NSI-189 compound) may lead to many great health stories and I daresay quite a few investors that may be able to retire off of this investment. The trick will be to hold on for the biggest part of the ride! GLTA longs, patients and their families.

    Sentiment: Buy

  • Reply to

    Adam F Is Coming For ALS Patients

    by analystveteran Jun 6, 2014 11:32 AM
    bnordheimer bnordheimer Jun 6, 2014 1:58 PM Flag

    Hey there, please do not throw the whole city in with this guy or with politicians! Not all Washingtonians are bad!!!

    Sentiment: Buy

DXCM
36.61+0.68(+1.89%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.